CTNM
Price
$3.90
Change
+$0.04 (+1.04%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
99.09M
GUTS
Price
$1.75
Change
-$0.09 (-4.89%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
102.85M
83 days until earnings call
Interact to see
Advertisement

CTNM vs GUTS

Header iconCTNM vs GUTS Comparison
Open Charts CTNM vs GUTSBanner chart's image
Contineum Therapeutics
Price$3.90
Change+$0.04 (+1.04%)
Volume$1.7K
Capitalization99.09M
Fractyl Health
Price$1.75
Change-$0.09 (-4.89%)
Volume$9.68K
Capitalization102.85M
CTNM vs GUTS Comparison Chart
Loading...
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTNM vs. GUTS commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTNM is a Hold and GUTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (CTNM: $3.86 vs. GUTS: $1.84)
Brand notoriety: CTNM and GUTS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTNM: 98% vs. GUTS: 97%
Market capitalization -- CTNM: $99.09M vs. GUTS: $102.85M
CTNM [@Biotechnology] is valued at $99.09M. GUTS’s [@Biotechnology] market capitalization is $102.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTNM’s FA Score shows that 1 FA rating(s) are green whileGUTS’s FA Score has 0 green FA rating(s).

  • CTNM’s FA Score: 1 green, 4 red.
  • GUTS’s FA Score: 0 green, 5 red.
According to our system of comparison, CTNM is a better buy in the long-term than GUTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTNM’s TA Score shows that 4 TA indicator(s) are bullish while GUTS’s TA Score has 6 bullish TA indicator(s).

  • CTNM’s TA Score: 4 bullish, 4 bearish.
  • GUTS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, GUTS is a better buy in the short-term than CTNM.

Price Growth

CTNM (@Biotechnology) experienced а +0.39% price change this week, while GUTS (@Biotechnology) price change was +19.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

CTNM is expected to report earnings on May 15, 2025.

GUTS is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GUTS($103M) and CTNM($99.1M) have the same market capitalization . GUTS YTD gains are higher at: -10.680 vs. CTNM (-73.686). CTNM has higher annual earnings (EBITDA): -42M vs. GUTS (-92.85M). CTNM has more cash in the bank: 205M vs. GUTS (67.5M). CTNM has less debt than GUTS: CTNM (6.26M) vs GUTS (62.5M). GUTS has higher revenues than CTNM: GUTS (93K) vs CTNM (0).
CTNMGUTSCTNM / GUTS
Capitalization99.1M103M96%
EBITDA-42M-92.85M45%
Gain YTD-73.686-10.680690%
P/E Ratio26.40N/A-
Revenue093K-
Total Cash205M67.5M304%
Total Debt6.26M62.5M10%
TECHNICAL ANALYSIS
Technical Analysis
CTNMGUTS
RSI
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
33%
Bullish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 8 days ago
69%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSQSX17.28N/A
N/A
Invesco MSCI World SRI Index R6
FIFWX23.87N/A
N/A
Fidelity Advisor Founders Z
PRACX45.65N/A
N/A
Putnam Research C
VGPMX14.91N/A
N/A
Vanguard Global Capital Cycles Investor
MRGKX54.76-0.99
-1.78%
MFS Core Equity R6

CTNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTNM has been loosely correlated with GUTS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CTNM jumps, then GUTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
+0.65%
GUTS - CTNM
34%
Loosely correlated
-12.38%
CCCC - CTNM
34%
Loosely correlated
-8.11%
SLN - CTNM
31%
Poorly correlated
N/A
ARMP - CTNM
29%
Poorly correlated
-6.67%
SVRA - CTNM
28%
Poorly correlated
-7.18%
More

GUTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GUTS has been loosely correlated with CABA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GUTS jumps, then CABA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GUTS
1D Price
Change %
GUTS100%
-12.38%
CABA - GUTS
36%
Loosely correlated
-4.52%
YMAB - GUTS
36%
Loosely correlated
-3.07%
IPSC - GUTS
35%
Loosely correlated
-3.40%
AKBA - GUTS
35%
Loosely correlated
-3.77%
GLUE - GUTS
35%
Loosely correlated
-3.61%
More